Infinimmune News and Activities

Acquisition, funding and merger involving Infinimmune.

• Infinimmune has just announced a $838 Million fundraising (posted on April 6 2026).

View the org chart displaying its 10 main executives

Most searched biographies at Infinimmune

• Wyatt Mcdonnell, Chief Executive Officer and Chairman of the Board
• Benjamin Kim, Director
• Neela Patel, Independent Board Director

Popular executive movements at Infinimmune

• Srikanth Pendyala has joined the company as Chief Medical Officer  (posted on May 13 2026).
• Anthony Slavin has joined the company as Senior Vice President of Portfolio Strategy  (posted on April 28 2026).

Create your alert
to follow the executive moves at Infinimmune.

Infinimmune has 2,406 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Infinimmune

Social media about Infinimmune

• Infinimmune on Wikipedia, Google News & Yahoo Finance
• Infinimmune on LinkedIn, X (Twitter) & YouTube